Mark W. Womack, visionnaire novateur, renforce le conseil d’administration de Bridgewest Perth Pharma Pty Ltd et amplifie ainsi la vision de croissance de NovaCina

Posted on by

Mark W. Womack nommé au conseil d’administration de Bridgewest Perth Pharma Pty Ltd MIAMI et PERTH, Australie, 6 mars 2024 /PRNewswire/ — Bridgewest Perth Pharma, une société mondiale d’approvisionnement et de fabrication de produits pharmaceutiques, avec ses filiales NovaCina et…

Posted in UncategorizedTagged
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.